Skip to content

Clinical trials

Phase 3 Hematologic Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 3 Country / region: Germany Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20102
20122
20132
20145
20171
20182
20192
20201
20216
20227
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting11
Terminated4
Recruiting3
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Pfizer4
Vertex Pharmaceuticals Incorporated4
Novartis Pharmaceuticals3
Agios Pharmaceuticals, Inc.2
CTI BioPharma2
Charite University, Berlin, Germany2
Genzyme, a Sanofi Company2
Seagen Inc.2
AOP Orphan Pharmaceuticals AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases33
Bone Marrow Diseases8
Genetic Diseases, Inborn7
Myeloproliferative Disorders7
Anemia6
Anemia, Sickle Cell6
Hemoglobinopathies5
Hemorrhagic Disorders5
Lymphoma5
Lymphoma, Non-Hodgkin5

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.